We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares

Delisted

AMYT was delisted on the 11th of April, 2023.

79 hedge funds and large institutions have $720M invested in Amryt Pharma plc American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 18

126% more capital invested

Capital invested by funds: $318M → $720M (+$402M)

57% more funds holding in top 10

Funds holding in top 10: 711 (+4)

39% more funds holding

Funds holding: 5779 (+22)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

100% less call options, than puts

Call options by funds: $20K | Put options by funds: $85.2M

Holders
79
Holders Change
+22
Holders Change %
+38.6%
% of All Funds
1.26%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.18%
New
42
Increased
8
Reduced
10
Closed
18
Calls
$20K
Puts
$85.2M
Net Calls
-$85.2M
Net Calls Change
-$85.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$5.33M +$4.19M +296,288 +429%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$4.73M +$4.58M +324,303 New
CL
28
CSS LLC
Illinois
$4.56M +$4.42M +312,886 New
SB
29
Samsara BioCapital
California
$4.44M
Wells Fargo
30
Wells Fargo
California
$4.08M -$196K -13,903 -5%
SCS
31
Syquant Capital SAS
France
$3.76M +$3.65M +258,000 New
CM
32
Capula Management
Cayman Islands
$3.59M +$3.48M +246,460 New
YCM
33
Yakira Capital Management
Connecticut
$3.06M +$2.97M +209,917 New
FLC
34
Fifth Lane Capital
Texas
$2.77M +$2.69M +190,244 New
N
35
Natixis
France
$2.77M +$2.69M +190,232 New
Jane Street
36
Jane Street
New York
$2.59M +$2.51M +177,421 New
GF
37
Gabelli Funds
New York
$2.45M +$2.38M +168,147 New
Goldman Sachs
38
Goldman Sachs
New York
$2.39M +$2.32M +163,968 New
AM
39
Anqa Management
New York
$2.29M +$2.21M +156,694 New
HM
40
Harvest Management
New York
$2.18M +$2.11M +149,500 New
PCM
41
PenderFund Capital Management
British Columbia, Canada
$1.88M +$1.35M +95,370 New
EPM
42
Equitec Proprietary Markets
Illinois
$1.82M +$1.76M +124,806 New
TC
43
Tejara Capital
United Kingdom
$1.77M
GCIA
44
Gabelli & Co Investment Advisers
New York
$1.67M +$1.62M +114,722 New
PFMU
45
Privium Fund Management (UK)
United Kingdom
$1.51M +$1.47M +103,775 New
CCM
46
Cinctive Capital Management
New York
$1.46M +$1.41M +100,000 New
Renaissance Technologies
47
Renaissance Technologies
New York
$1.44M +$717K +50,700 +106%
QOP
48
Quinn Opportunity Partners
Virginia
$1.25M +$1.22M +86,000 New
CF
49
Cantor Fitzgerald
New York
$1.2M
AA
50
AlphaCentric Advisors
Puerto Rico
$1.18M

AMYT Hedge Fund Activity: Q1 2023 in Review

79 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q1 2023, worth a combined $720M — up 126% from $318M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMYT positions and 18 closed out — a net gain of 24 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $35.3M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $26.3M sold.

  • 79 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q1 2023, up from 57 in Q4 2022.
  • Funds reported $720M of Amryt Pharma plc American Depositary Shares stock for Q1 2023, up 126% quarter-over-quarter.
  • 42 funds opened new Amryt Pharma plc American Depositary Shares positions in Q1 2023 and 18 closed out, a net change of +24 holders.
  • The largest Amryt Pharma plc American Depositary Shares buyer in Q1 2023 was Pentwater Capital Management, an estimated $35.3M added.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q1 2023 was Rubric Capital Management (New York), an estimated $26.3M sold.

Based on aggregated 13F filings for Q1 2023.